Women's Health

Patient Expectations Linked to Clinical Outcome from Endocrine Treatment

Patient Expectations Linked to Clinical Outcome from Endocrine Treatment

Negative patient expectations are associated with an increased risk of adverse events in patients with breast cancer undergoing endocrine therapy.

Breast Cancer Tumors Often a Composite of Tumor Types, Enhancing Treatment Resistance

Breast Cancer Tumors Often a Composite of Tumor Types, Enhancing Treatment Resistance

Estrogen receptor (ER)-positive breast cancers are often not a single tumor but a composite of related tumors, referred to as sub-clones.

Hormone Receptor Test Results in DCIS Core Needle Biopsy Not Used, Not Needed

Hormone Receptor Test Results in DCIS Core Needle Biopsy Not Used, Not Needed

Routine testing for hormone receptors in tissue obtained in a first needle biopsy for ductal carcinoma in situ (DCIS).

Chemotherapy During Pregnancy May Limit Baby's Fertility in Girls

Chemotherapy During Pregnancy May Limit Baby's Fertility in Girls

Etoposide was found to damage ovarian tissue in the developing fetus in a study evaluating the effect of the drug on mouse ovarian tissue grown in vitro.

Early Tumor Size Change May Predict OS in Metastatic Breast Cancer

Early Tumor Size Change May Predict OS in Metastatic Breast Cancer

Change in tumor size at week 8 may predict overall survival during first-line therapy in patients with metastatic breast cancer.

Physical Activity May Reduce Mortality by 44% in Patients With Breast Cancer

Physical Activity May Reduce Mortality by 44% in Patients With Breast Cancer

Participation in exercise may reduce mortality compared with nonparticipation in patients with breast cancer.

Weight Loss Through Diet Improves Risks for Cancer in Overweight/Obese Women

Weight Loss Through Diet Improves Risks for Cancer in Overweight/Obese Women

Losing weight through diet or diet and exercise improves risk for cancer in overweight or obese postmenopausal women. Although exercise alone can help maintain weight loss, it is not as effective as diet and exercise.

New Guidelines Establish Safe Surgery Margins for DCIS

New Guidelines Establish Safe Surgery Margins for DCIS

Consensus guideline states that a 2 mm margin is enough to guard against recurrences while reducing need for additional operations for women with DCIS who undergo breast-conserving surgery.

ESR1 Mutations Prevalent in ER+ Metastatic Breast Cancer

ESR1 Mutations Prevalent in ER+ Metastatic Breast Cancer

ESR1 mutations are more frequent in patients with estrogen receptor (ER)-positive metastatic breast cancer that are treated with aromatase inhibitors, according to recent study data.

Novel Pathway Improves Access to Genetic Testing for Women With Ovarian Cancer

Novel Pathway Improves Access to Genetic Testing for Women With Ovarian Cancer

Rapid, robust, and affordable genetic testing for patients with ovarian cancer that allows a much larger portion of patients to benefit from personalized cancer management and their relatives to benefit from preventive strategies can be achieved.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs